Valuation of Attendo AB : a fundamental analysis of a nordic healthcare company
Master thesis
Permanent lenke
http://hdl.handle.net/11250/2611653Utgivelsesdato
2019Metadata
Vis full innførselSamlinger
- Master Thesis [4378]
Sammendrag
The objective of this thesis is to estimate the intrinsic value of Attendo AB using fundamental
analysis by applying a discounted cash flow valuation using the weighted average cost of
capital method. A relative valuation approach is applied to support the result from the
discounted cash flow method. The healthcare industry for care services in the Nordic region
is thoroughly assessed, alongside a strategic analysis of firm-specific attributes and factors, in
order to make assumptions about future performance of Attendo.
As healthcare services in the Nordics has experienced increasing privatization, new markets
for private providers have opened up. Governments in the Nordics have created healthcare
reforms over the last decades in an attempt to modernize and improve the services offered in
the industry. The phenomenon of an ageing population and demands for better quality and
more user-autonomy, has fueled these developments. These developments are not likely to
change in the foreseeable future, and the future market of care services is expected to be carried
out by a higher proportion of private providers than what is the case today. In this regard,
Attendo is in a strong strategic position as it is a large player with experience, in an emerging
market.
The result of this fundamental analysis is an estimated share price of SEK 46 for Attendo AB,
which imply that the stock is currently undervalued by approximately SEK 4. Although this
valuation is based upon assumptions about future performance that entails uncertainty, which
is discussed in a sensitivity analysis, the overall conclusion is a sell recommendation.